Phase II Trial of an Oral FGFR Inhibitor AZD4547 as Second or Third Line Therapy in Malignant Pleural Mesothelioma: Final Results of FRAME Study

W. Lam, A. Nowak, F. Chen, S. Muruganandan, S. Arunachalam, M. Chin, M. Millward, C. Read, K. Murray, J. Creaney, Y. C. G. Lee

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Pages (from-to)S342-S342
Number of pages1
JournalJournal of Thoracic Oncology
Volume14
Issue number10
DOIs
Publication statusPublished - Oct 2019

Cite this